What is Alamar Biosciences 's R&D?

Alamar Biosciences (ALMR) reported R&D of $13.02M in Q1 2026.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Alamar Biosciences ALMR R&D

R&D at other companies

VicorVICR

$22.29M+15.0%

PTCPTC

$124.13M+11.8%

HasbroHAS

$78M-3.1%

Tempus AI, Inc.TEM

$48.24M+34.5%

AccentureACN

$204.33M-29.0%

Ford Motor CompanyF

$2.35B+17.5%

Other financials

Income statement

See full

Revenue$26.0M+98.9%

Gross profit$14.5M+126%

Operating income-$12.3M-44.4%

Net income-$21.3M-178%

EPS (diluted)-$1.74-156%

Balance sheet

See full

Cash & equivalents$64.6M—

Total debt$30.6M—

Total equity-$178.1M—

Total assets$186.5M—

Cash flow

See full

Operating cash flow-$20.3M-55.7%

CapEx$600.0K+8.3%

Free cash flow-$20.9M-53.8%

Valuation

See full

Market cap$1.52B—

Enterprise value$1.49B—

Returns & leverage

See full

Debt / equity-0.2×—

Current ratio5.9×—

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alamar Biosciences 's R&D?: Alamar Biosciences (ALMR) reported R&D of $13.02M in Q1 2026.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.